Given that recent experiments in cell lines suggested that Drak2 negatively regulates TGF-β signaling [12], and enhanced TGF-β signaling in T cells could contribute to the resistance to autoimmune disease, we tested whether Drak2 functions as a negative regulator of TGF-β signaling in T cells. This evidence concerns the gene STK17B and autoimmune disease.